Candel Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $274k | 54k | 5.10 |
| 2025-06-30 | $276k | 55k | 5.06 |
| 2025-03-31 | $188k | 33k | 5.65 |
| 2024-12-31 | $228k | 26k | 8.68 |
| 2024-09-30 | $156k | 23k | 6.93 |
| 2024-06-30 | $143k | 23k | 6.20 |